JHU's Neurofibromatosis Therapeutic Acceleration Program celebrated the 10th anniversary of its Francis S. Collins Scholars ...

Kerstin Bettermann, M.D., chief of neurology for UPMC Neurological Institute and hospital services in Central and North ...

Recently, an existing drug called ubrogepant went through phase 3 clinical trials demonstrating that it can also be used to stop migraine headaches before they even start and could help with ...

Considering a migraine clinical trial? Learn about the types, benefits, risks, and eligibility, along with what questions you should ask to see if participating is right for you.